Geneguide (https://www.geneguide.com/) is a spin-off company of the University of Basel, founded 2013, and directed by the two founders Andreas Papassotiropoulos and Dominique de Quervain, who share more than 18 years of scientific collaboration. Geneguide uses a human genome-based approach to identify new drug targets and compounds for the treatment of neuropsychiatric disorders.
The 2 founders have published numerous milestone publications in leading journals, such as Nature, Science, Cell, Nature Neuroscience, Nature Communications, Nature Human Behaviour, Neuron, and PNAS on the neurobiological foundations of human cognitive and emotional functions and clinical trials.
GeneGuide AG
Birmannsgasse 8
4055 Basel
Switzerland
Geneguide(at)brainscience.ch